KAYO MOTOR
834058
Zhejiang Zoenn Design
300901
Zhejiang Meorient Commerce & Exhibition Inc.
300795
Fujian Zitian Media Technology
300280
Zhejiang Prulde Electric Appliance
301353
CN Stock MarketDetailed Quotes
000627 Hubei Biocause Pharmaceutical
- 4.86
- -0.27-5.26%
Market Closed Dec 13 15:00 CST
24.01BMarket Cap-31.15P/E (TTM)
5.24High4.80Low3.96MlotVolume5.13Open5.13Pre Close1.96BTurnover8.70%Turnover RatioLossP/E (Static)4.94BShares5.4252wk High1.10P/B22.13BFloat Cap1.6152wk Low5.64Limit Up4.55BShs Float16.97Historical High4.62Limit Down8.58%Amplitude0.45Historical Low--Dividend TTM4.95Avg Price2.02MlotAsk--Div YieldTTM100Lot Size1.86MlotBid
Hubei Biocause Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -18.43%33.6B | -13.08%29.06B | -20.25%17.49B | 0.17%49.7B | 8.88%41.19B | 21.13%33.43B | 20.38%21.93B | 0.07%49.62B | 6.60%37.83B | 20.40%27.6B |
| Operating revenue | -18.43%33.6B | -13.08%29.06B | -20.25%17.49B | 0.17%49.7B | 8.88%41.19B | 21.13%33.43B | 20.38%21.93B | 0.07%49.62B | 6.60%37.83B | 20.40%27.6B |
| Total operating cost | -18.66%33.85B | -12.55%29.48B | -19.14%17.61B | 4.39%51.54B | 12.08%41.62B | 23.88%33.7B | 20.76%21.78B | 0.34%49.37B | 5.95%37.13B | 21.18%27.21B |
| Other operating cost | -45.87%1.59B | -44.90%1.15B | -37.67%665.96M | 7.38%3.73B | 18.16%2.93B | 25.93%2.08B | 31.75%1.07B | 18.49%3.47B | 16.36%2.48B | 24.30%1.65B |
| Operating tax surcharges | 41.35%74.64M | 43.19%53.14M | 33.25%25.78M | 7.14%81.52M | -4.27%52.8M | -2.80%37.11M | -9.42%19.34M | 8.40%76.08M | 9.30%55.16M | 18.36%38.18M |
| Asset Impairment Loss | ---- | ---- | ---- | 1,533.26%2.68B | --454.38M | ---- | ---- | -84.67%163.94M | ---- | ---- |
| Special items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3,475.79%-1.86B | 51.01%-19.43M | 70.18%-10.36M |
| Other net revenue | ||||||||||
| Fair value change income | 8.41%213.77M | -64.59%74.34M | -71.70%57.78M | 135.18%151.9M | 142.00%197.18M | 157.49%209.95M | 150.05%204.16M | -2,169.61%-431.84M | -120.30%-469.47M | -246.91%-365.2M |
| Invest income | -0.68%5.07B | -4.42%3.45B | -15.29%1.69B | -30.32%7.27B | -39.01%5.1B | -34.52%3.61B | -33.87%1.99B | 0.46%10.43B | 6.69%8.36B | 7.09%5.52B |
| -Including: Investment income associates | -56.52%63.58M | -49.17%37.83M | -0.46%25.47M | -70.13%104.88M | -54.83%146.22M | -71.77%74.42M | -69.55%25.58M | -13.99%351.18M | 31.62%323.7M | 199.96%263.59M |
| Exchange income | -143.57%-9.59M | -127.49%-6.76M | 95.71%-237.2K | -71.58%20.47M | -72.87%22.02M | -44.95%24.58M | -109.59%-5.53M | 573.76%72.02M | 2,216.75%81.17M | 644.37%44.66M |
| Asset deal income | 2,235.23%1.76M | 1,011.03%1.67M | 1,660.57%1.87M | 128.82%952.83K | -170.75%-82.46K | -160.15%-183.71K | -146.97%-119.69K | 197.37%416.41K | 232.41%116.55K | 3,275.06%305.41K |
| Other revenue | 176.81%27.55M | 193.82%26.63M | 389.80%19.7M | -74.18%17.38M | -84.51%9.95M | -46.30%9.06M | -3.81%4.02M | -30.75%67.3M | -25.20%64.24M | -79.37%16.87M |
| Operating profit | 40.86%-253.15M | -53.61%-417.14M | -181.33%-122.18M | -849.56%-1.84B | -161.25%-428.06M | -169.12%-271.56M | -17.16%150.23M | -35.74%245.59M | 57.94%698.85M | -16.66%392.9M |
| Add:Non operating Income | -26.12%6.87M | -21.02%6.6M | -33.55%5.85M | -53.50%10.78M | 154.51%9.3M | 352.93%8.35M | 743.91%8.8M | 165.32%23.18M | -53.98%3.65M | -19.26%1.84M |
| Less:Non operating expense | 27.42%35.63M | 20.32%25.28M | 19.22%10.54M | -13.77%37.93M | -17.88%27.97M | -16.10%21.01M | -31.23%8.84M | -8.00%43.99M | 4.99%34.05M | 44.05%25.04M |
| Total profit | 36.89%-281.91M | -53.34%-435.82M | -184.47%-126.87M | -931.04%-1.87B | -166.83%-446.73M | -176.88%-284.22M | -11.41%150.2M | -34.49%224.78M | 59.92%668.45M | -18.99%369.71M |
| Less:Income tax cost | 1,428.50%362.55M | 206.12%275.35M | -30.74%45.34M | -105.19%-586.5M | -112.00%-27.29M | 114.20%89.95M | 159.56%65.47M | 46.78%-285.84M | 198.30%227.47M | 131.31%41.99M |
| Net profit | -53.65%-644.46M | -90.07%-711.16M | -303.24%-172.21M | -350.97%-1.28B | -195.11%-419.44M | -214.17%-374.16M | -69.68%84.73M | -41.99%510.62M | -32.09%440.98M | -44.50%327.71M |
| Net profit from continuing operation | -53.65%-644.46M | -90.07%-711.16M | -303.24%-172.21M | -350.97%-1.28B | -195.11%-419.44M | -214.17%-374.16M | -69.68%84.73M | -41.99%510.62M | -32.09%440.98M | -44.50%327.71M |
| Less:Minority Profit | -50.82%-311.36M | -85.33%-346.14M | -308.30%-82.34M | -366.20%-629.74M | -201.51%-206.44M | -223.22%-186.77M | -70.09%39.53M | -42.23%236.57M | -31.50%203.37M | -45.02%151.57M |
| Net profit of parent company owners | -56.39%-333.1M | -94.79%-365.02M | -298.82%-89.88M | -337.82%-651.76M | -189.64%-213M | -206.39%-187.4M | -69.31%45.21M | -41.78%274.05M | -32.59%237.61M | -44.05%176.14M |
| Earning per share | ||||||||||
| Basic earning per share | -56.38%-0.0674 | -94.74%-0.074 | -282.00%-0.0182 | -316.67%-0.13 | -189.60%-0.0431 | -205.56%-0.038 | -66.67%0.01 | -40.00%0.06 | -32.54%0.0481 | -43.75%0.036 |
| Diluted earning per share | -56.38%-0.0674 | -94.74%-0.074 | -282.00%-0.0182 | -316.67%-0.13 | -189.60%-0.0431 | -205.56%-0.038 | -66.67%0.01 | -40.00%0.06 | -32.54%0.0481 | -43.75%0.036 |
| Other composite income | 7,090.98%3.09B | 17.14%523.13M | -84.05%90.73M | 130.65%835.74M | 101.42%42.96M | 129.07%446.57M | 126.86%568.98M | -239.31%-2.73B | -262.97%-3.02B | -908.15%-1.54B |
| Other composite income of parent company owners | 7,189.88%1.58B | 16.87%266.71M | -84.01%46.37M | 130.67%426.33M | 101.40%21.61M | 129.13%228.22M | 126.84%289.88M | -239.27%-1.39B | -262.91%-1.54B | -908.09%-783.4M |
| Other composite income of minority owners | 6,990.91%1.51B | 17.43%256.42M | -84.10%44.36M | 130.63%409.41M | 101.44%21.35M | 129.00%218.35M | 126.88%279.1M | -239.35%-1.34B | -263.03%-1.48B | -908.22%-752.81M |
| Total composite income | 749.42%2.44B | -359.68%-188.03M | -112.46%-81.48M | 79.88%-445.76M | 85.42%-376.48M | 105.99%72.41M | 135.55%653.71M | -178.10%-2.22B | -203.09%-2.58B | -254.82%-1.21B |
| Total composite income of parent company owners | 748.96%1.24B | -340.81%-98.31M | -112.99%-43.51M | 79.80%-225.43M | 85.31%-191.39M | 106.72%40.82M | 135.93%335.08M | -175.98%-1.12B | -200.38%-1.3B | -247.48%-607.26M |
| Total composite income of minority owners | 749.89%1.2B | -384.07%-89.72M | -111.92%-37.97M | 79.97%-220.33M | 85.52%-185.09M | 105.25%31.59M | 135.16%318.63M | -180.37%-1.1B | -206.02%-1.28B | -263.02%-601.24M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Asia Pacific Accounting Firm (Special General Partnership) | -- | -- | -- | China Audit Asia Pacific Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.